Septerna (SEPN) Change in Accured Expenses (2023 - 2026)
Septerna (SEPN) recorded quarterly Change in Accured Expenses of -$3.5 million in Q1 2026, down 181.42% quarter-over-quarter from $4.3 million in Q4 2025, and down 2.52% on a YoY basis from -$3.6 million in Q1 2025.
Septerna (SEPN) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Septerna's Change in Accured Expenses history runs 4 years deep, the most recent figure standing at -$3.5 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 2.52% year-over-year to -$3.5 million; the TTM figure through Mar 2026 stood at $4.3 million (up 146.22% YoY), while the FY2025 annual figure was $4.4 million, up 22.31% from the prior year.
- Change in Accured Expenses was -$3.5 million for Q1 2026 at Septerna, down from $4.3 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $4.3 million in Q4 2025 to a low of -$3.5 million in Q1 2026.
- Historically, Change in Accured Expenses has averaged $630200.0 across 4 years, with a median of $1.6 million in 2023.
- Biggest YoY gain for Change in Accured Expenses was 795.8% in 2025; the steepest drop was 113.11% in 2025.
- A 4-year view of Change in Accured Expenses shows it stood at $1.9 million in 2023, then soared by 56.12% to $3.0 million in 2024, then soared by 45.36% to $4.3 million in 2025, then plunged by 181.42% to -$3.5 million in 2026.
- The last three Change in Accured Expenses figures came in at -$3.5 million (Q1 2026), $4.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | -3.45 Mn |
| Mar 31, 2025 | -3.45 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | -1.62 Mn |
| Mar 31, 2024 | -1.62 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Dec 31, 2023 | 1.91 Mn |